SCHNEYER MARK C. (Chief Financial Officer) sold 10.9% of their position (7.38K shares) of ACADIA PHARMACEUTICALS INC on the open market
Open‑market sale worth $159.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+8.14K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−4.18K
Price / share
$21.47
Trade value
$89.68K
% of position
Common Stock
Shares
+6.18K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−3.17K
Price / share
$21.65
Trade value
$68.65K
% of position
Common Stock
Shares
−37.00
Price / share
$21.72
Trade value
$803.54
% of position
Net shares
+6.93K
Net value
-$159.14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/24/2026 | M · Option Exercise | +8.14K | — | — | 15.3% | 53.34K | 61.48K |
| Common Stock Direct | 3/25/2026 | S · Sale | −4.18K | $21.47 | $89.68K | 6.8% | 61.48K | 57.30K |
| Common Stock Direct | 3/25/2026 | M · Option Exercise | +6.18K | — | — | 10.8% | 57.30K | 63.48K |
| Common Stock Direct | 3/26/2026 | S · Sale | −3.17K | $21.65 | $68.65K | 5.0% | 63.48K | 60.31K |
| Common Stock Direct | 3/26/2026 | S · Sale | −37.00 | $21.72 | $803.54 | 0.1% | 60.31K | 60.27K |
| Total | +6.93K | -$159.14K | ||||||
Restricted Stock Units
Common Stock
8.14K shares
Shares
−8.14K
Strike price
Held after
24.41K
Exercisable
—
Restricted Stock Units
Common Stock
6.18K shares
Shares
−6.18K
Strike price
Held after
12.36K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock8.14K shares | 3/24/2026 | M · Option Exercise | −8.14K | — | 24.41K | |
| Restricted Stock Units Direct | Common Stock6.18K shares | 3/25/2026 | M · Option Exercise | −6.18K | — | 12.36K |